NYSE:GSK - GlaxoSmithKline Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$41.60 +0.39 (+0.95 %)
(As of 03/26/2019 04:00 PM ET)
Previous Close$41.21
Today's Range$41.51 - $41.87
52-Week Range$36.41 - $42.36
Volume2.45 million shs
Average Volume2.89 million shs
Market Capitalization$103.19 billion
P/E Ratio13.16
Dividend Yield5.73%
Beta0.76

Analyst Ratings

GlaxoSmithKline (NYSE:GSK) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
18 Wall Street analysts have issued ratings and price targets for GlaxoSmithKline in the last 12 months. Their average twelve-month price target is $41.39, suggesting that the stock has a possible downside of 0.50%. The high price target for GSK is $47.00 and the low price target for GSK is $36.95. There are currently 1 sell rating, 13 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.172.222.322.43
Ratings Breakdown: 1 Sell Rating(s)
13 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
12 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
11 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $41.39$41.39$41.1583$40.7125
Price Target Upside: 0.50% downside2.10% upside9.32% upside1.27% upside

GlaxoSmithKline (NYSE:GSK) Consensus Price Target History

Price Target History for GlaxoSmithKline (NYSE:GSK)

GlaxoSmithKline (NYSE:GSK) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/8/2019Shore CapitalDowngradeBuy ➝ HoldLowView Rating Details
2/22/2019UBS GroupDowngradeBuy ➝ NeutralLowView Rating Details
1/14/2019Exane BNP ParibasDowngradeOutperform ➝ NeutralMediumView Rating Details
12/14/2018Morgan StanleyInitiated CoverageUnderweightLowView Rating Details
12/13/2018SunTrust BanksInitiated CoverageHold$38.00LowView Rating Details
12/11/2018Jefferies Financial GroupReiterated RatingBuy ➝ Buy$45.00LowView Rating Details
12/6/2018BarclaysReiterated RatingOverweight ➝ Equal WeightMediumView Rating Details
12/4/2018CfraReiterated RatingHoldMediumView Rating Details
12/3/2018JPMorgan Chase & Co.Reiterated RatingNeutralLowView Rating Details
10/23/2018Wolfe ResearchInitiated CoverageMarket PerformMediumView Rating Details
10/10/2018Goldman Sachs GroupReiterated RatingBuyLowView Rating Details
10/8/2018GuggenheimInitiated CoverageNeutral ➝ NeutralLowView Rating Details
8/30/2018Liberum CapitalDowngradeBuy ➝ HoldLowView Rating Details
8/20/2018ArgusBoost Price TargetBuy ➝ Buy$45.00 ➝ $47.00LowView Rating Details
8/1/2018Deutsche BankReiterated RatingNeutralLowView Rating Details
7/25/2018Bank of AmericaSet Price TargetHold$40.00MediumView Rating Details
6/14/2018DZ BankReiterated RatingBuyLowView Rating Details
2/15/2018CowenReiterated RatingHold$40.00LowView Rating Details
2/9/2018Kepler Capital MarketsUpgradeReduce ➝ HoldLowView Rating Details
11/6/2017InvestecDowngradeBuy ➝ HoldN/AView Rating Details
7/27/2017CitigroupReiterated RatingNeutralLowView Rating Details
5/26/2017Berenberg BankUpgradeHold ➝ BuyLowView Rating Details
(Data available from 3/26/2017 forward)
This page was last updated on 3/26/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel